Helius Therapeutics announced it has secured an all-new commercial Medicinal Cannabis Licence to cultivate and process active cannabis ingredients. Helius Therapeutics’ is New Zealand’s largest cannabis company and is now set to open an 8,800sqm state-of-the-art medicinal cannabis cultivation and manufacturing facility in East Tamaki, Auckland. The Ministry of Health’s new Medicinal Cannabis Agency granted the license under the new scheme which took effect in April 2020. “This is the strongest indication yet that patients can expect high quality, affordable, certified New Zealand Grown cannabis medicines as soon as early next year. Helius is in a commanding position, with a truly world-class team and now the commercial license to bring our products together with prescribes and their patients,” says Paul Manning, Chief Executive of Helius Therapeutics. Helius’ cannabis production facility will be one of the largest and most innovative facilities in the Southern Hemisphere. It’s also one of the first new medicines manufacturing facilities to be built in New Zealand over the last decade.
Mmp News Author, Medical Marijuana Program Connection, 08/18/2020 02:25:09
Open article: https://mmpconnect.com/helius-secures-commercial-medicinal-cannabis-licence/